ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity
暂无分享,去创建一个
S. Hautaniemi | M. Varjosalo | T. Pellinen | Kaiyang Zhang | Kari Salokas | D. Ungureanu | A. Murumägi | S. Staff | K. Veskimäe | Juuli Raivola | Alice Dini | Emilia Piki | K. Välimäki
[1] O. Kallioniemi,et al. Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention , 2022, Cell Death & Disease.
[2] M. Varjosalo,et al. New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome , 2022, Cellular and Molecular Life Sciences.
[3] Min Li,et al. The impact of STAT3 and phospho-STAT3 expression on the prognosis and clinicopathology of ovarian cancer: a systematic review and meta-analysis , 2021, Journal of Ovarian Research.
[4] Katja Kaipio,et al. PRISM: recovering cell-type-specific expression profiles from individual composite RNA-seq samples , 2021, Bioinform..
[5] A. Bleckmann,et al. The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention , 2021, Cells.
[6] K. Nyangoh Timoh,et al. The Landscape and Therapeutic Implications of Molecular Profiles in Epithelial Ovarian Cancer , 2020, Journal of clinical medicine.
[7] S. Knapp,et al. Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases. , 2020, Molecular cell.
[8] A. Regev,et al. A single-cell landscape of high-grade serous ovarian cancer , 2020, Nature Medicine.
[9] Y. Kakeji,et al. Mesenchymal stem cell‐derived CXCL16 promotes progression of gastric cancer cells by STAT3‐mediated expression of Ror1 , 2020, Cancer science.
[10] R. Jain,et al. A framework for advancing our understanding of cancer-associated fibroblasts , 2020, Nature Reviews Cancer.
[11] B. Davidson,et al. Expression of Wnt pathway molecules is associated with disease outcome in metastatic high-grade serous carcinoma , 2020, Virchows Archiv.
[12] Emanuela M. Ghia,et al. Cirmtuzumab Blocks Wnt5a/ROR1-Stimulation Of NF-κB To Repress Autocrine STAT3-Activation In Chronic Lymphocytic Leukemia. , 2019, Blood.
[13] H. Kohler,et al. Glucocorticoids promote breast cancer metastasis , 2019, Nature.
[14] Harlan R. Barker,et al. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting , 2019, Oncogene.
[15] M. Nykter,et al. Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies1 , 2018, Translational oncology.
[16] E. Llamosas,et al. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer. , 2018, Gynecologic oncology.
[17] C. Ford,et al. Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer1 , 2017, Translational oncology.
[18] P. Goodfellow,et al. Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target , 2017, Oncogene.
[19] M. Boutros,et al. Wnt signaling in cancer , 2016, Oncogene.
[20] E. Llamosas,et al. Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer , 2016, Oncogenesis.
[21] V. Beral,et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer , 2015, Nature Reviews Cancer.
[22] E. Ghia,et al. Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy , 2014, Proceedings of the National Academy of Sciences.
[23] L. Trusolino,et al. The ROR1 pseudokinase diversifies signaling outputs in MET‐addicted cancer cells , 2014, International journal of cancer.
[24] Hua Yu,et al. Revisiting STAT3 signalling in cancer: new and unexpected biological functions , 2014, Nature Reviews Cancer.
[25] E. Llamosas,et al. The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. , 2014, Gynecologic oncology.
[26] C. Sander,et al. Evaluating cell lines as tumour models by comparison of genomic profiles , 2013, Nature Communications.
[27] G. Mills,et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth , 2011, Nature Medicine.
[28] Z. Estrov,et al. Stat3 Activates the Receptor Tyrosine Kinase Like Orphan Receptor-1 Gene in Chronic Lymphocytic Leukemia Cells , 2010, PloS one.
[29] Hua Yu,et al. STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.
[30] Ben S. Wittner,et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 , 2009, Nature.